AGT and diabetic kidney disease: Moreover, Ogawa et al. [31] demonstrated that angiotensin II receptor blocker (ARB) treatment reduces urinary Alb levels at the stage of microalbuminuria underlying diabetic nephropathy when the urinary oxidative stress marker and AGT are high.